A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

PHASE3CompletedINTERVENTIONAL
Enrollment

1,459

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

July 29, 2024

Study Completion Date

March 18, 2025

Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL

RSVPreF3 OA investigational vaccine

1 dose of RSVPreF3 OA investigational vaccine is administered intramuscularly on Day 1.

Trial Locations (52)

1459

GSK Investigational Site, Reiger Park

2010

GSK Investigational Site, Sydney

2065

GSK Investigational Site, Sydney

2113

GSK Investigational Site, Johannesburg

2450

GSK Investigational Site, Coffs Harbour

3021

GSK Investigational Site, St Albans

3051

GSK Investigational Site, Melbourne

4006

GSK Investigational Site, Fortitude Valley

4121

GSK Investigational Site, Tarragindi

7530

GSK Investigational Site, Cape Town

7700

GSK Investigational Site, Cape Town

10117

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

13347

GSK Investigational Site, Berlin

14609

GSK Investigational Site, Rochester

20904

GSK Investigational Site, Silver Spring

22911

GSK Investigational Site, Charlottesville

32806

GSK Investigational Site, Orlando

33012

GSK Investigational Site, Hialeah

33173

GSK Investigational Site, North Miami

37909

GSK Investigational Site, Knoxville

40509

GSK Investigational Site, Lexington

45355

GSK Investigational Site, Essen

55116

GSK Investigational Site, Mainz

58455

GSK Investigational Site, Witten

69469

GSK Investigational Site, Weinheim

73111

GSK Investigational Site, Oklahoma City

75115

GSK Investigational Site, DeSoto

85284

GSK Investigational Site, Phoenix

85308

GSK Investigational Site, Glendale

94574

GSK Investigational Site, Wallerfing

94598

GSK Investigational Site, Walnut Creek

94610

GSK Investigational Site, Oakland

97070

GSK Investigational Site, Würzburg

98801

GSK Investigational Site, Wenatchee

91606-3287

GSK Investigational Site, North Hollywood

V3L 3W4

GSK Investigational Site, New Westminster

V8V 4A1

GSK Investigational Site, Victoria

B2N 1L2

GSK Investigational Site, Truro

P3C 1X3

GSK Investigational Site, Greater Sudbury

N1G 0B4

GSK Investigational Site, Guelph

N5W 6A2

GSK Investigational Site, London-Ontario

M4G 3E8

GSK Investigational Site, Toronto

G1N 4V3

GSK Investigational Site, Québec

G1V 4G2

GSK Investigational Site, Québec

G1V 4W2

GSK Investigational Site, Québec

J6E 2B4

GSK Investigational Site, Saint-Charles-Borromée

J1J 2G2

GSK Investigational Site, Sherbrooke

300-0062

GSK Investigational Site, Ibaraki

211-0041

GSK Investigational Site, Kanagawa

155-0031

GSK Investigational Site, Tokyo

180-0022

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY